// Pipeline

A focused portfolio across modalities.

Programs are organized by therapeutic area. Details may evolve as data matures.

VLV-111

Cell Therapy - CAR

STAGE

Discovery

Preclinical Development

Phase 1

VLV-121

Targeted Therapy - mAb

STAGE

Discovery

Preclinical Development

Phase 1

VLV-211

Immunotherapy

STAGE

Discovery

Preclinical Development

Phase 1